Skip to main content

What the FDA labels say about taking them together

Clarithromycin and digoxin

Clarithromycin's FDA label of April 9, 2026 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name clarithromycin.

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the clarithromycin label say about digoxin?

Clarithromycin label, drug interactions

Digoxin Use With Caution Digoxin: Digoxin is a substrate for P-glycoprotein (Pgp) and clarithromycin is known to inhibit Pgp.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the digoxin label say about clarithromycin?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name clarithromycin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
26Digoxin generic labelers
ClarithromycinDigoxin
Labeled forBacterial infections, Acid reflux and ulcersHeart failure, Atrial fibrillation
Boxed warningNoNo
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tablet$0.133 per tablet 125 mcg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?